A case of epirubicin-associated cardiotoxicity progressing to life-threatening heart failure and splenic thromboembolism

Internal Medicine

Volumn 51, Issue 11, 2012, Pages 1355-1360

  Okura, Yuji ^a   Kawasaki, Takashi ^a   Kanbayashi, Chizuko ^a   Sato, Nobuaki ^a  

^a NIIGATA CANCER CENTER HOSPITAL   (Japan)

Author keywords

Cardiotoxicity; Epirubicin; Thromboembolism

Indexed keywords

AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; AMIODARONE; BISOPROLOL; CD45RO ANTIGEN; DIGOXIN; DIURETIC AGENT; DOBUTAMINE; ENALAPRIL; EPIRUBICIN; FUROSEMIDE; HEPARIN; IODOFILTIC ACID I 123; OXYGEN; PIMOBENDAN; SPIRONOLACTONE; THALLIUM 201; TROPONIN T; VASODILATOR AGENT; WARFARIN;

ACUTE HEART FAILURE; ADULT; AMBULATORY MONITORING; APPETITE DISORDER; ARTICLE; CARDIOMEGALY; CARDIOTOXICITY; CASE REPORT; DYSPNEA; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAPHY; ELECTRON MICROSCOPY; FATIGUE; FEMALE; HEART CATHETERIZATION; HEART LEFT VENTRICLE EJECTION FRACTION; HEART MUSCLE BIOPSY; HEART MUSCLE INJURY; HEART MUSCLE METABOLISM; HEART MUSCLE NECROSIS; HEART SOUND; HEART VENTRICLE TACHYCARDIA; HUMAN; HUMAN TISSUE; HYPOKINESIA; HYPOTENSION; IMMUNOHISTOCHEMISTRY; LIVER CONGESTION; LUNG CONGESTION; R WAVE; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; SINUS TACHYCARDIA; THORAX RADIOGRAPHY; THROMBOEMBOLISM; WEIGHT GAIN;

ADULT; ANTINEOPLASTIC AGENTS; BREAST NEOPLASMS; EPIRUBICIN; FEMALE; FIBRIN FIBRINOGEN DEGRADATION PRODUCTS; HEART FAILURE; HUMANS; NATRIURETIC PEPTIDE, BRAIN; PEPTIDE FRAGMENTS; SPLEEN; THROMBOEMBOLISM; TROPONIN T;

EID: 84863087720     PISSN: 09182918     EISSN: 13497235     Source Type: Journal    
DOI: 10.2169/internalmedicine.51.6973     Document Type: Article

References (11)

1. Wojnowski L, Kulle B, Schirmer M, et al. NAD(P)H oxidase and multi drug resistance protein genetic polymorphisms are associated with doxorubicin-induced cardiotoxicity. Circulation 112: 3754-3762, 2005.
2. von Hoff DD, Layard MW, Basa P, et al. Risk factors for doxorubicin-induced congestive heart failure. Ann Intern Med 91: 710-717, 1979.
3. Smith LA, Cornelius VR, Plummer CJ, et al. Cardiotoxicity of an-thracycline agents for the treatment of cancer: systematic review and meta-analysis of randomised controlled trials. BMC Cancer 10: 337, 2010.
4. Ryberg M, Nielsen D, Cortese G, et al. New insight into epirubicin cardiac toxicity: competing risks analysis of 1097 breast cancer patients. J Natl Cancer Inst 100: 1058-1067, 2008.
5. Torti FM, Bristow MM, Lum BL, et al. Cardiotoxicity of epirubicin and doxorubicin: assessment by endomyocardial biopsy. Cancer Res 46: 3722-3727, 1986.
6. Bristow MR, Mason JW, Billingham ME, Daniels JR. Doxorubi-cin cardiomyopathy: evaluation by phonocardiography, endomyo-cardial biopsy, and cardiac catheterization. Ann Intern Med 88: 168-175, 1978.
7. Goldfarb LG, Dalakas MC. Tragedy in a heartbeat: malfunctioning desmin causes skeletal and cardiac muscle disease. J Clin Invest 119: 1806-1813, 2009.
8. Ouyang J, Guzman M, Desoto-Lapaix F, Pincus MR, Wieczorek R. Utility of desmin and a Masson's trichrome method to detect early acute myocardial infarction in autopsy tissues. Int J Clin Exp Pathol 3: 98-105, 2009.
9. Singal PK, Deally CM, Weinberg LE. Sub cellular effects of adria-mycin in the heart: a concise review. J Mol Cell Cardiol 19: 817-828, 1987.
10. Bristow MR, Thompson PD, Martin RP, et al. Early anthracycline cardiotoxicity. Am J Med 65: 823-832, 1978.
11. Gaudin PB, Hruban RH, Beschorner WE, et al. Myocarditis associated with doxorubicin cardiotoxicity. Am J Clin Pathol 100: 158-163, 1993.